基于基因表达模型预测儿童中危经典型霍奇金淋巴瘤预后
研究利用儿童肿瘤协作组AHOD0031试验中246例儿童经典型霍奇金淋巴瘤(cHL)的FFPE组织进行基因表达谱分析,并与成人cHL数据比较。发现儿童肿瘤微环境以嗜酸性粒细胞、B细胞和肥大细胞特征为主,成人则以巨噬细胞和基质特征为主。
要点
- 儿童与成人cHL肿瘤微环境基因表达特征存在差异。
- 成人cHL预后模型在儿童cHL中未获验证。
- 9细胞组分模型可预测儿童中危cHL的EFS。
核心结论
- 儿童青少年cHL具有独特的肿瘤微环境生物学,可用于诊断时风险分层。
研究设计与样本
- 回顾性分析儿童肿瘤协作组AHOD0031试验中246例儿童cHL的FFPE组织活检,进行基因表达谱分析并与成人cHL数据比较,开发并验证预后模型。
主要发现
- 儿童cHL中嗜酸性粒细胞、B细胞和肥大细胞特征富集,成人中巨噬细胞和基质特征更突出。
- 既往成人cHL总生存预测模型在儿童cHL中未获验证。
临床怎么用
- 该模型可在诊断时辅助儿童中危cHL的风险分层,但需进一步外部验证。
局限性
- 研究基于AHOD0031试验样本,外部适用性需验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Classical Hodgkin lymphoma (cHL) is a common malignancy in children and adolescents. Although cHL is highly curable, treatment with chemotherapy and radiation often come at the cost of long-term toxicity and morbidity. Effective risk-stratification tools are needed to tailor therapy. Here, we used gene expression profiling (GEP) to investigate tumor microenvironment (TME) biology, to determine molecular correlates of treatment failure, and to develop an outcome model prognostic for pediatric cHL. A total of 246 formalin-fixed, paraffin-embedded tissue biopsies from patients enrolled in the Children's Oncology Group trial AHOD0031 were used for GEP and compared with adult cHL data. Eosinophil, B-cell, and mast cell signatures were enriched in children, whereas macrophage and stromal signatures were more prominent in adults. Concordantly, a previously published model for overall survival prediction in adult cHL did not validate in pediatric cHL. Therefore, we developed a 9-cellular component model reflecting TME composition to predict event-free survival (EFS). In an independent validation cohort, we observed a significant difference in weighted 5-year EFS between high-risk and low-risk groups (75.2% vs 90.3%; log-rank P = .0138) independent of interim response, stage, fever, and albumin. We demonstrate unique disease biology in children and adolescents that can be harnessed for risk-stratification at diagnosis. This trial was registered at www.clinicaltrials.gov as #NCT00025259.
引用
- Johnston RL, Mottok A, Chan FC, et al. A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma. Blood. 2022. PMID: 34662378. doi:10.1182/blood.2021011941
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。